Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

  • There is currently no data for N4P

Distribution Agreement

13 Oct 2009 07:00

RNS Number : 6499A
Ultima Networks PLC
13 October 2009
Β 

ο»Ώ

13Β October 2009

ULTIMA NETWORKS Plc ("Ultima")

Distribution Agreement with MakroΒ UK

Ultima Networks Plc,Β theΒ AIM listedΒ green technology company,Β is pleased to announce that its Electric Bicycle DivisionΒ has enteredΒ into an agreement withΒ MakroΒ UKΒ to supplyΒ it with Ultima'sΒ range ofΒ electric cycles. MakroΒ UKΒ is a major cash and carry wholesaler operating in theΒ UK. Initially,Β 27 MakroΒ UKΒ stores across the country will sellΒ Ultima'sΒ high quality, mid-rangeΒ PowaCycle Salisbury LPX, andΒ Ultima expectsΒ otherΒ electric bicycleΒ modelsΒ Β to be introducedΒ in the near future.

MakroΒ UKΒ is part of the Metro Group, the world's cash & carry leader, which has over 600 stores in 30 countries. It sells a wide selection of goods tailored specially to the needs of its many thousands of retail and wholesale customers.

Wassim Mughal,Β MDΒ of Electric Bicycle Division,Β commented: "The PowerCycle Salisbury LPX is one of the most popular electric bicycles ever to be sold in theΒ UK. We are confident thatΒ its sales will be even more buoyantΒ now that it is being offered by Makro - our first national chain of stores."

ends

Contact:

Ultima NetworksΒ Plc

HumayunΒ Mughal,Β CEOΒ Ultima NetworksΒ plc 01279Β 821Β 200

Allenby Capital Limited

Nick Naylor/Nick Athanas 0203 328 5661

Threadneedle Communications

Graham Herring/Alex White 020 7653 9850

AboutΒ Ultima Networks Plc

UltimaΒ operates threeΒ divisions:

Β IT and related services -Β Β develops and supplies computer-based application software and services to the legal profession
Green TechnologyΒ Β -Β responsible for the design,Β development and distribution ofΒ electric bicyclesΒ and other green technology products
Green Power -Β Β involved in the development of solar power parksΒ inΒ ItalyΒ andSpain

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGRUURBRKORRAAA
Date   Source Headline
23rd May 202412:19 pmRNSResult of AGM
29th Apr 202410:59 amRNSPosting of Annual Report & Notice of AGM
26th Apr 20247:00 amRNSN4 Pharma Webinar on SRI Collaboration
25th Apr 20247:38 amRNSCollaboration Agreement with SRI International Inc
23rd Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSOral Delivery Update
4th Mar 20243:13 pmRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSin-vitro siRNA update
19th Jan 20247:00 amRNSPatent Grant
18th Jan 202410:15 amRNSHolding(s) in Company
16th Jan 20247:00 amRNSNanogenics Update
8th Jan 20244:24 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSAAV Viral Vector Update
18th Dec 20237:00 amRNSOral Delivery Update
7th Dec 202311:28 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSNuvec® R&D and Strategy Update
30th Nov 20239:00 amRNSN4 Pharma Launches New Interactive Investor Hub
31st Oct 20237:00 amRNSTotal Voting Rights
9th Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Oct 20238:15 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSInvestor Presentation
28th Sep 20237:00 amRNSAcquisition of Controlling Interest in Nanogenics
12th Sep 20237:00 amRNSInterim Results
25th Jul 20237:00 amRNSPatent Grant and Board Change
27th Jun 20237:00 amRNSGrant Award for Professor Chengzhong Yu
25th Apr 20237:00 amRNSsiRNA update
18th Apr 20237:00 amRNSsiRNA update
3rd Apr 20232:11 pmRNSResult of AGM
9th Mar 20237:00 amRNSPosting of Annual Report & Notice of AGM
9th Mar 20237:00 amRNSFinal Results
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20232:05 pmRNSSecond Price Monitoring Extn
17th Jan 20232:00 pmRNSPrice Monitoring Extension
17th Jan 202311:05 amRNSSecond Price Monitoring Extn
17th Jan 202311:00 amRNSPrice Monitoring Extension
17th Jan 20239:05 amRNSSecond Price Monitoring Extn
17th Jan 20239:00 amRNSPrice Monitoring Extension
17th Jan 20237:00 amRNSOral application update
30th Nov 20225:28 pmRNSHolding(s) in Company
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20222:49 pmRNSHolding(s) in Company
22nd Nov 202210:50 amRNSResult of Broker Offer and Total Voting Rights
18th Nov 20227:01 amRNSBroker Offer to raise a maximum of £1 million
18th Nov 20227:00 amRNSPlacing to raise £1million and Broker Offer
1st Nov 20227:00 amRNSPatent filing update
4th Oct 20227:00 amRNSDouble siRNA Testing Update
29th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSOperational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.